LEADER 01346nam  2200361Ia 450 
001 9910699050803321
005 20090821135927.0
035   $a(CKB)5470000002399378
035   $a(OCoLC)432326260
035   $a(EXLCZ)995470000002399378
100   $a20090821d2002      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $einformation program on clinical trials for serious or life-threatening diseases and conditions
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2002]
215   $a1 online resource (9 pages) $cdigital, PDF file
300   $a"Center for Biologics Evaluation and Research (CBER)."
300   $a"Procedural."
300   $a"March 2002."
517   $aGuidance for industry 
606   $aClinical trials$xGovernment policy$zUnited States
615  0$aClinical trials$xGovernment policy
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699050803321
996   $aGuidance for industry$93434577
997   $aUNINA